American Vanguard Corp. (AVD) Forecasted to Post Q3 2018 Earnings of $0.20 Per Share

American Vanguard Corp. (NYSE:AVD) – Stock analysts at SunTrust Banks cut their Q3 2018 earnings estimates for American Vanguard in a research note issued to investors on Wednesday, August 8th. SunTrust Banks analyst J. Sheehan now anticipates that the basic materials company will post earnings of $0.20 per share for the quarter, down from their prior estimate of $0.24. SunTrust Banks also issued estimates for American Vanguard’s Q4 2018 earnings at $0.23 EPS, FY2018 earnings at $0.78 EPS and FY2019 earnings at $0.93 EPS.

Other analysts also recently issued research reports about the stock. Zacks Investment Research downgraded shares of American Vanguard from a “buy” rating to a “hold” rating in a report on Thursday, May 17th. ValuEngine downgraded shares of American Vanguard from a “buy” rating to a “hold” rating in a report on Wednesday, August 8th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $25.00.

American Vanguard stock opened at $19.50 on Monday. American Vanguard has a fifty-two week low of $18.01 and a fifty-two week high of $24.00. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.05 and a quick ratio of 1.09. The company has a market capitalization of $588.29 million, a P/E ratio of 34.21 and a beta of 1.01.

American Vanguard (NYSE:AVD) last posted its earnings results on Monday, August 6th. The basic materials company reported $0.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.17 by $0.02. American Vanguard had a net margin of 5.45% and a return on equity of 6.29%. The firm had revenue of $107.04 million during the quarter, compared to the consensus estimate of $111.90 million. During the same quarter last year, the firm earned $0.15 EPS. The firm’s revenue for the quarter was up 37.4% on a year-over-year basis.

Hedge funds have recently modified their holdings of the business. Piedmont Investment Advisors LLC purchased a new position in American Vanguard in the 2nd quarter valued at approximately $141,000. SG Americas Securities LLC purchased a new position in American Vanguard in the 2nd quarter valued at approximately $219,000. OppenheimerFunds Inc. purchased a new position in American Vanguard in the 2nd quarter valued at approximately $233,000. Victory Capital Management Inc. boosted its position in American Vanguard by 84.3% in the 1st quarter. Victory Capital Management Inc. now owns 13,468 shares of the basic materials company’s stock valued at $272,000 after buying an additional 6,161 shares during the period. Finally, MetLife Investment Advisors LLC purchased a new position in American Vanguard in the 4th quarter valued at approximately $293,000. 77.20% of the stock is owned by institutional investors.

In other American Vanguard news, insider Peter Porpiglia sold 2,800 shares of the firm’s stock in a transaction that occurred on Monday, June 11th. The shares were sold at an average price of $23.47, for a total value of $65,716.00. Following the completion of the transaction, the insider now owns 24,557 shares of the company’s stock, valued at approximately $576,352.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO David` T. Johnson sold 9,940 shares of the firm’s stock in a transaction that occurred on Monday, July 23rd. The shares were sold at an average price of $20.91, for a total transaction of $207,845.40. Following the completion of the transaction, the chief financial officer now directly owns 36,095 shares of the company’s stock, valued at approximately $754,746.45. The disclosure for this sale can be found here. Company insiders own 5.20% of the company’s stock.

About American Vanguard

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

See Also: Investing in Growth Stocks

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply